Correlation Between Pacira BioSciences, and Cardiol Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pacira BioSciences, and Cardiol Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pacira BioSciences, and Cardiol Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pacira BioSciences, and Cardiol Therapeutics Class, you can compare the effects of market volatilities on Pacira BioSciences, and Cardiol Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pacira BioSciences, with a short position of Cardiol Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pacira BioSciences, and Cardiol Therapeutics.
Diversification Opportunities for Pacira BioSciences, and Cardiol Therapeutics
-0.71 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Pacira and Cardiol is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Pacira BioSciences, and Cardiol Therapeutics Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiol Therapeutics and Pacira BioSciences, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pacira BioSciences, are associated (or correlated) with Cardiol Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiol Therapeutics has no effect on the direction of Pacira BioSciences, i.e., Pacira BioSciences, and Cardiol Therapeutics go up and down completely randomly.
Pair Corralation between Pacira BioSciences, and Cardiol Therapeutics
Given the investment horizon of 90 days Pacira BioSciences, is expected to under-perform the Cardiol Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Pacira BioSciences, is 1.74 times less risky than Cardiol Therapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The Cardiol Therapeutics Class is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 70.00 in Cardiol Therapeutics Class on September 4, 2024 and sell it today you would earn a total of 87.00 from holding Cardiol Therapeutics Class or generate 124.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pacira BioSciences, vs. Cardiol Therapeutics Class
Performance |
| Timeline |
| Pacira BioSciences, |
| Cardiol Therapeutics |
Pacira BioSciences, and Cardiol Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pacira BioSciences, and Cardiol Therapeutics
The main advantage of trading using opposite Pacira BioSciences, and Cardiol Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pacira BioSciences, position performs unexpectedly, Cardiol Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiol Therapeutics will offset losses from the drop in Cardiol Therapeutics' long position.| Pacira BioSciences, vs. Phibro Animal Health | Pacira BioSciences, vs. Dr Reddys Laboratories | Pacira BioSciences, vs. Collegium Pharmaceutical | Pacira BioSciences, vs. Silver Spike Investment |
| Cardiol Therapeutics vs. Flora Growth Corp | Cardiol Therapeutics vs. ABVC Biopharma | Cardiol Therapeutics vs. Indaptus Therapeutics | Cardiol Therapeutics vs. HCW Biologics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |